Reviv3 Procare CO RVIV
We take great care to ensure that the data presented and summarized in this overview for Reviv3 Procare Co is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in RVIV
Top Purchases
Top Sells
About RVIV
Reviv3 Procare Company manufactures, markets, distributes, and sells hair and skin care products in the United States, Canada, Europe, and Asia. Its hair care products include PREP shampoos, PRIME conditioners, and TREAT maintenance care products. The company also offers BOOST to deliver nutrients and enhance circulation to the scalp; MEND deep hair repair masks for added moisture; and PROTECT, a heat protectant product to prevent damage from irons and dryers, as well as thickening sprays for giving hair more volume and body. In addition, it provides creams and lotions; and perfumes, mouthwashes, and deodorants, as well as shaving, makeup, and nail products. Further, the company offers hearing enhancement and protection products, including ear plugs, ear muffs, and ear buds under the AXIL brand. It serves business-to-business salon through its network of domestic and international distributors; and direct-to-consumer marketing programs through its ecommerce site and various third-party online platforms, as well as retail chains. Reviv3 Procare Company was incorporated in 2015 and is based in El Monte, California.
Insider Transactions at RVIV
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 14
2024
|
Manu Ohri Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
Feb 14
2024
|
Peter Philip Dunne Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+16.0%
|
-
|
Feb 14
2024
|
Nancy Hundt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+40.74%
|
-
|
Oct 18
2023
|
Jeff Toghraie Chairman, CEO |
BUY
Open market or private purchase
|
Indirect |
2,100,000
+7.77%
|
$0
$0.12 P/Share
|
Oct 18
2023
|
Nancy Hundt Director |
SELL
Open market or private sale
|
Direct |
2,100,000
-97.88%
|
$0
$0.12 P/Share
|
Apr 10
2023
|
Jeff Toghraie Chairman, CEO |
BUY
Other acquisition or disposition
|
Indirect |
15,000,000
+39.39%
|
-
|
Feb 10
2023
|
Jeffrey B. Brown CFO, COO |
SELL
Open market or private sale
|
Direct |
2,500
-0.82%
|
$0
$0.42 P/Share
|
Feb 08
2023
|
Jeffrey B. Brown CFO, COO |
SELL
Open market or private sale
|
Direct |
2,655
-0.43%
|
$0
$0.46 P/Share
|
Jan 30
2023
|
Jeffrey B. Brown CFO, COO |
SELL
Open market or private sale
|
Direct |
1,000
-0.32%
|
$0
$0.29 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 15K shares |
---|